| Dr Eduardo Sebastian Antezano, MD | |
|
1215 Pleasant St, Ste 414, Des Moines, IA 50309-1416 | |
| (515) 241-5700 | |
| (515) 241-5775 |
| Full Name | Dr Eduardo Sebastian Antezano |
|---|---|
| Gender | Male |
| Speciality | Cardiovascular Disease (cardiology) |
| Experience | 28 Years |
| Location | 1215 Pleasant St, Des Moines, Iowa |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1447363486 | NPI | - | NPPES |
| 1447363486 | Medicaid | IA | |
| P01371808 | Other | IA | RR MEDICARE |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 036-102068 (Illinois) | Secondary |
| 207RC0000X | Internal Medicine - Cardiovascular Disease | 37277 (Iowa) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Unitypoint Health - Des Moines Iowa Methodist Medi | Des moines, IA | Hospital |
| Unitypoint Health-marshalltown | Marshalltown, IA | Hospital |
| Grinnell Regional Medical Center | Grinnell, IA | Hospital |
| Stewart Memorial Community Hospital | Lake city, IA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Central Iowa Hospital Corporation | 1052229275 | 159 |
News Archive
Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.
Dr. Akhilesh K. Gaharwar, associate professor, has developed a highly printable bioink as a platform to generate anatomical-scale functional tissues. This study was recently published in the American Chemical Society's Applied Materials and Interfaces.
Fluorescence imaging is widely used for visualizing biological tissues such as the back of the eye, where signs of macular degeneration can be detected. It is also commonly used to image blood vessels during reconstructive surgery, allowing surgeons to make sure the vessels are properly connected.
TaiGen Biotechnology Company, Limited today announced that together with its distribution partner, Holding Distribution, it has launched Taigexyn (nemonoxacin) capsules in Taiwan, the first market where Taigexyn is available.
Movements so minute they cannot be detected by the human eye are being analyzed by researchers to diagnose autism spectrum disorder and determine its severity in children and young adults, according to research presented at the 2013 Society for Neuroscience annual meeting in November.
› Verified 7 days ago
| Entity Name | Central Iowa Hospital Corporation |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104879576 PECOS PAC ID: 1052229275 Enrollment ID: O20040128001102 |
News Archive
Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.
Dr. Akhilesh K. Gaharwar, associate professor, has developed a highly printable bioink as a platform to generate anatomical-scale functional tissues. This study was recently published in the American Chemical Society's Applied Materials and Interfaces.
Fluorescence imaging is widely used for visualizing biological tissues such as the back of the eye, where signs of macular degeneration can be detected. It is also commonly used to image blood vessels during reconstructive surgery, allowing surgeons to make sure the vessels are properly connected.
TaiGen Biotechnology Company, Limited today announced that together with its distribution partner, Holding Distribution, it has launched Taigexyn (nemonoxacin) capsules in Taiwan, the first market where Taigexyn is available.
Movements so minute they cannot be detected by the human eye are being analyzed by researchers to diagnose autism spectrum disorder and determine its severity in children and young adults, according to research presented at the 2013 Society for Neuroscience annual meeting in November.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Eduardo Sebastian Antezano, MD 1582 Nw 131st St, Clive, IA 50325-7430 Ph: (515) 457-3886 | Dr Eduardo Sebastian Antezano, MD 1215 Pleasant St, Ste 414, Des Moines, IA 50309-1416 Ph: (515) 241-5700 |
News Archive
Tarsa Therapeutics, Inc. today announced that it has secured a $10 million senior credit facility from Oxford Finance LLC and Square 1 Bank. The company intends to use the proceeds to support its plans to file a New Drug Application (NDA) with the U.S. Food and Drug Administration for its Ostora tablet for the treatment of postmenopausal osteoporosis, currently targeted for early 2015.
Dr. Akhilesh K. Gaharwar, associate professor, has developed a highly printable bioink as a platform to generate anatomical-scale functional tissues. This study was recently published in the American Chemical Society's Applied Materials and Interfaces.
Fluorescence imaging is widely used for visualizing biological tissues such as the back of the eye, where signs of macular degeneration can be detected. It is also commonly used to image blood vessels during reconstructive surgery, allowing surgeons to make sure the vessels are properly connected.
TaiGen Biotechnology Company, Limited today announced that together with its distribution partner, Holding Distribution, it has launched Taigexyn (nemonoxacin) capsules in Taiwan, the first market where Taigexyn is available.
Movements so minute they cannot be detected by the human eye are being analyzed by researchers to diagnose autism spectrum disorder and determine its severity in children and young adults, according to research presented at the 2013 Society for Neuroscience annual meeting in November.
› Verified 7 days ago
Dr. Joshua C Lukenbill, D.O. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant Street, Suite 100, Des Moines, IA 50309 Phone: 515-282-2921 Fax: 515-282-1035 | |
Dr. Akshay Mahesh Khatri, M.B.B.S., MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048 | |
Dr. Ravinder K Dervesh, MD Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 411 Laurel St Ste 1225, Des Moines, IA 50314 Phone: 515-633-3770 Fax: 515-288-6713 | |
Mr. David Augusto Terrero Salcedo, M.D Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1221 Pleasant St Ste 300, Des Moines, IA 50309 Phone: 515-241-4200 Fax: 515-241-4048 | |
Tyler Mumm, DO Cardiovascular Disease Medicare: Not Enrolled in Medicare Practice Location: 1111 6th Ave, Des Moines, IA 50314 Phone: 515-643-2261 Fax: 515-643-5802 | |
Bilal Hasan Baig, DO Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 1200 Pleasant St, Des Moines, IA 50309 Phone: 515-241-6636 Fax: 515-241-4080 | |
Dr. Sean D Cunningham, M.D. Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1215 Pleasant St, Ste 206, Des Moines, IA 50309 Phone: 515-875-9092 Fax: 515-875-9828 |